{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:12:08Z","timestamp":1760145128342,"version":"build-2065373602"},"reference-count":66,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["RCR-2020-23670065"],"award-info":[{"award-number":["RCR-2020-23670065"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Atrial fibrillation (AF) has been associated with higher morbidity and mortality rates, especially in older patients. Subclinical atrial fibrillation (SCAF) is defined as the presence of atrial high-rate episodes (AHREs) &gt; 190 bpm for 10 consecutive beats &gt; 6 min and &lt;24 h, as detected by cardiac implanted electronic devices (CIEDs). The selection of eligible patients for anticoagulation therapy among elderly individuals with AHREs detected through CIEDs remains a contentious issue. The meta-analysis of ARTESiA and NOAH-AFNET 6 clinical trials revealed that taking Edoxaban or Apixaban as oral anticoagulation therapy can reduce the risk of stroke by approximately 32% while increasing the risk of major bleeding by approximately 62%. However, it is still unclear which are, among patients with SCAF, those who can take the highest net clinical benefit from anticoagulant therapy. The present review summarizes the current evidence on this intriguing issue and suggests strategies to try to better stratify the risk of stroke and systemic embolism in patients with AHREs. We propose incorporating some parameters including chronic kidney disease (CKD), obesity, enlarged left atrial volume, the efficacy in blood pressure management, and frailty into the traditional CHA2DS2-VASc score. Future trials will be needed to verify the clinical usefulness of the proposed prognostic score mainly in the view of a personalized therapeutic approach in patients with SCAF.<\/jats:p>","DOI":"10.3390\/jcm13123566","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T07:33:20Z","timestamp":1718696000000},"page":"3566","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atrial High-Rate Episodes in Elderly Patients: The Anticoagulation Therapy Dilemma"],"prefix":"10.3390","volume":"13","author":[{"given":"Lorenzo","family":"Pimpini","sequence":"first","affiliation":[{"name":"Cardiology Unit, IRCCS INRCA, Via della Montagnola 81, 60127 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-9432","authenticated-orcid":false,"given":"Leonardo","family":"Biscetti","sequence":"additional","affiliation":[{"name":"Neurology Unit, IRCCS INRCA, 60127 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Matacchione","sequence":"additional","affiliation":[{"name":"Clinic of Laboratory and Precision Medicine, IRCCS INRCA, 60121 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Giammarchi","sequence":"additional","affiliation":[{"name":"Scientific Direction, IRCCS INRCA, 60127 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-5792","authenticated-orcid":false,"given":"Michelangela","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Antonicelli","sequence":"additional","affiliation":[{"name":"Cardiology Unit, IRCCS INRCA, Via della Montagnola 81, 60127 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: The Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): A prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0041-1726332","article-title":"Atrial Fibrillation and Ischemic Stroke: A Clinical Review","volume":"41","author":"Migdady","year":"2021","journal-title":"Semin. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.117.030583","article-title":"Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study","volume":"136","author":"Halcox","year":"2017","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2022.06.023","article-title":"Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression","volume":"103","author":"Proietti","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e022487","DOI":"10.1161\/JAHA.121.022487","article-title":"Atrial High-Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta-Analysis","volume":"10","author":"Sagris","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5830\/CVJA-2020-052","article-title":"Atrial high-rate episodes: A comprehensive review","volume":"32","author":"Simu","year":"2021","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamacardio.2021.3702","article-title":"Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke","volume":"6","author":"Singer","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.117.028845","article-title":"Subclinical Atrial Fibrillation in Older Patients","volume":"136","author":"Healey","year":"2017","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.121.057014","article-title":"Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial","volume":"145","author":"Lubitz","year":"2022","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamacardio.2021.0038","article-title":"Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial","volume":"6","author":"Gladstone","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): A multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ackd.2017.08.001","article-title":"Sodium Homeostasis in Chronic Kidney Disease","volume":"24","author":"Soi","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00424-014-1668-y","article-title":"Salt feedback on the renin-angiotensin-aldosterone system","volume":"467","author":"Schweda","year":"2015","journal-title":"Pflugers Arch."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12933-023-01913-5","article-title":"Obesity and atrial fibrillation: A narrative review from arrhythmogenic mechanisms to clinical significance","volume":"22","author":"Shu","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.21037\/atm-20-4387","article-title":"Metabolically healthy obesity and risk of stroke: A meta-analysis of prospective cohort studies","volume":"9","author":"Ma","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1161\/STROKEAHA.120.033016","article-title":"Obesity and Risk for First Ischemic Stroke Depends on Metabolic Syndrome: The HUNT Study","volume":"52","author":"Horn","year":"2021","journal-title":"Stroke"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2180373","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccep.2020.11.002","article-title":"Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology","volume":"13","author":"Harada","year":"2021","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yamagami, F., Tajiri, K., Yumino, D., and Ieda, M. (2019). Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications. Toxins, 11.","DOI":"10.3390\/toxins11100597"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1960","DOI":"10.1212\/WNL.0000000000207852","article-title":"Interplay Between Chronic Kidney Disease, Hypertension, and Stroke: Insights From a Multivariable Mendelian Randomization Analysis","volume":"101","author":"Kelly","year":"2023","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e022560","DOI":"10.1161\/JAHA.121.022560","article-title":"Causal Effect of Obstructive Sleep Apnea on Atrial Fibrillation: A Mendelian Randomization Study","volume":"10","author":"Chen","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: An interdisciplinary perspective","volume":"42","author":"Simons","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_33","first-page":"120","article-title":"Obstructive sleep apnea and stroke","volume":"2","author":"Jehan","year":"2018","journal-title":"Sleep. Med. Disord."},{"key":"ref_34","first-page":"16","article-title":"Atrial fibrillation and gastroesophageal reflux disease: The cardiogastric interaction","volume":"19","author":"Linz","year":"2017","journal-title":"Europace"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e26502","DOI":"10.1097\/MD.0000000000026502","article-title":"Reflux esophagitis is associated with higher risks of acute stroke and transient ischemic attacks in patients hospitalized with atrial fibrillation: A nationwide inpatient sample analysis","volume":"100","author":"Jiang","year":"2021","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1131250","DOI":"10.3389\/fneur.2023.1131250","article-title":"Stroke and the risk of gastrointestinal disorders: A Mendelian randomization study","volume":"14","author":"Song","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1295051","DOI":"10.3389\/fneur.2023.1295051","article-title":"Association between gastroesophageal reflux disease and stroke: A bidirectional Mendelian randomization study","volume":"14","author":"Meng","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4022\/jafib.1556","article-title":"Atrial Fibrillation in Hypertrophic Cardiomyopathy: Diagnosis and Considerations for Management","volume":"10","author":"Patten","year":"2018","journal-title":"J. Atr. Fibrillation"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Vitolo, M., Proietti, M., Imberti, J.F., Bonini, N., Romiti, G.F., Mei, D.A., Malavasi, V.L., Diemberger, I., Fauchier, L., and Marin, F. (2023). Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12030768"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fneur.2020.00026","article-title":"Left Atrial Enlargement and the Risk of Stroke: A Meta-Analysis of Prospective Cohort Studies","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2015.08.033","article-title":"Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database","volume":"66","author":"Klungel","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e006490","DOI":"10.1161\/JAHA.117.006490","article-title":"Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA(2)DS(2)-VASc Scores","volume":"6","author":"Roldan","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: Definition and natural history","volume":"27","author":"Xue","year":"2011","journal-title":"Clin. Geriatr. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/gerona\/glp076","article-title":"Nonlinear multisystem physiological dysregulation associated with frailty in older women: Implications for etiology and treatment","volume":"64","author":"Fried","year":"2009","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s43587-020-00017-z","article-title":"The physical frailty syndrome as a transition from homeostatic symphony to cacophony","volume":"1","author":"Fried","year":"2021","journal-title":"Nat. Aging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Theou, O., Squires, E., Mallery, K., Lee, J.S., Fay, S., Goldstein, J., Armstrong, J.J., and Rockwood, K. (2018). What do we know about frailty in the acute care setting? A scoping review. BMC Geriatr., 18.","DOI":"10.1186\/s12877-018-0823-2"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jamda.2015.06.025","article-title":"Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis","volume":"16","author":"Kojima","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_50","first-page":"105","article-title":"Atrial fibrillation and frailty","volume":"17","author":"Guo","year":"2020","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101652","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_52","first-page":"424","article-title":"Sarcopenia, frailty, cognitive impairment and mortality in elderly patients with non-valvular atrial fibrillation","volume":"219","author":"Gullon","year":"2019","journal-title":"Rev. Clin. Esp."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afn293","article-title":"The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation","volume":"38","author":"Perera","year":"2009","journal-title":"Age Ageing"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, J., Chai, K., Zhu, W., Du, M., Meng, C., Yang, L., Cui, L., Guo, D., Sun, N., and Wang, H. (2023). Implication of different frailty criteria in older people with atrial fibrillation: A prospective cohort study. BMC Geriatr., 23.","DOI":"10.1186\/s12877-023-04330-1"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","article-title":"Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation","volume":"211","author":"Madhavan","year":"2019","journal-title":"Am. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"afac192","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wilkinson, C., Wu, J., Searle, S.D., Todd, O., Hall, M., Kunadian, V., Clegg, A., Rockwood, K., and Gale, C.P. (2020). Clinical outcomes in patients with atrial fibrillation and frailty: Insights from the ENGAGE AF-TIMI 48 trial. BMC Med., 18.","DOI":"10.1186\/s12916-020-01870-w"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.archger.2015.01.016","article-title":"Frailty in NHANES: Comparing the frailty index and phenotype","volume":"60","author":"Blodgett","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/STROKEAHA.123.044407","article-title":"Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study","volume":"55","author":"Sogaard","year":"2024","journal-title":"Stroke"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02982161","article-title":"The I.A.N.A Task Force on frailty assessment of older people in clinical practice","volume":"12","author":"Rolland","year":"2008","journal-title":"J. Nutr. Health Aging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2018.04.018","article-title":"Frailty and atrial fibrillation: A systematic review","volume":"56","author":"Villani","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation","volume":"390","author":"Healey","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2024.01.002","article-title":"Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?","volume":"123","author":"Boriani","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/12\/3566\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:00:28Z","timestamp":1760108428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/12\/3566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["jcm13123566"],"URL":"https:\/\/doi.org\/10.3390\/jcm13123566","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}